After yesterday's announcement ,morningstar decreased their FVE down by 22%.
The biggest impact they had was that their chances of a successful launch for MPC-150-IM to 15% from 25%.
Our big question now should be whether the result from the IIb trial (being done independently) take away some of the credibility from the original phase II trial.
Morning Star Decrease their Target price from $2.90 to $2.35
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.0¢ |
Change
0.010(1.02%) |
Mkt cap ! $1.130B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.02 | 98.5¢ | $5.507M | 5.501M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9996 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 18069 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |